Evaluation of pharmacokinetic interactions between lobeglitazone, empagliflozin, and metformin in healthy subjects

Concomitant administration of lobeglitazone, empagliflozin, and metformin is expected to enhance blood glucose-lowering effects and improve medication compliance in patients with diabetes mellitus. In this study, we investigated the pharmacokinetic (PK) interactions and safety of lobeglitazone and c...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Heeyoung, Kim, Choon Ok, Park, Hyeonsoo, Park, Min Soo, Kim, Dasohm, Hong, Taegon, Shin, Yesong, Jin, Byung Hak
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society for Clinical Pharmacology and Therapeutics 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10079507/
https://www.ncbi.nlm.nih.gov/pubmed/37034122
http://dx.doi.org/10.12793/tcp.2023.31.e4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10079507/
https://www.ncbi.nlm.nih.gov/pubmed/37034122
http://dx.doi.org/10.12793/tcp.2023.31.e4

Ejemplares similares